Please select a press release to review from the following options:
November 19, 2008
Viral Genetics, Inc. Completes Acquisition of V-Clip Pharmaceuticals, Inc.
Click here for more.
October 21, 2008
Viral Genetics, Inc. Releases Initial Findings of Lyme Disease Study.
Click here for more.
October 08, 2008
Viral Genetics, Inc. Invited to Present New Model, Initial Findings of Lyme Disease Study at Prestigious ILADS Conference.
Click here for more.
September 10, 2008
New Study Building off Viral Genetics' Research Aims to Unlock the Mysteries behind Lyme Disease and Other Immune Based Diseases Including HIV/AIDS.
Click here for more.
September 02, 2008
Form 8-K for VIRAL GENETICS INC /DE/. Unregistered Sale of Equity Securities, Financial Statements and Exhibits.
Click here for more.
August 19, 2008
Viral Genetics, Inc. Unveils Potential Mechanism of Action in HIV/AIDS Research, Accepted to Present Findings at Prestigious IHV Meeting.
Click here for more.
August 08, 2008
Unregistered Sale of Equity Securities. Item 3.02 Unregistered Sales of Equity Securities.
Click here for more.
August 06, 2008
Viral Genetics, Inc. Appoints C. Everett Koop as Special Advisor to Board of Directors.
Click here for more.
July 08, 2008
Unregistered Sale of Equity Securities, Financial Statements and Exhibits.
Click here for more.
March 19, 2008
Marshall C. Phelps, Richard T. Gerstner and Anthony Freda, Jr. Join Viral Genetics, Inc. Business Advisory Board and Invest in Private Placement.
Click here for more.
March 12, 2008
Dutton Associates Announces Investment Opinion: Viral Genetics Rating At Neutral In Update Coverage By Dutton Associates.
Click here for more.
February 05, 2008
Viral Genetics Updates Progress on Technology Acquired From University of Colorado.
Click here for more.
December 20, 2007
Viral Genetics Announces Licensing Deal With University of Colorado and V-Clip Pharmaceuticals, Inc.
Click here for more.
August 2, 2007
Viral Genetics Appoints Scientific Development Manager to Focus on Translational Studies.
Click here for more.
April 17, 2007
Viral Genetics Builds African Advisory Team.
Click here for more.
March 21, 2007
Viral Genetics Updates Scientific Milestones.
Click here for more.
March 13, 2007
Viral Genetics Restructures Convertible Debentures.
Click here for more.
January 25, 2007
Dutton Associates Announces Investment Opinion: Viral Genetics rating speculative buy in upgrade by Dutton Associates.
Click here for more.
January 09, 2007
Viral Genetics identifies crucial peptides for potential HIV/AIDS Drug.
Click here for more.
December 07, 2006
Viral Genetics to Present at New York Society of Security Analysts 10th Annual Biotech and Specialty Pharmaceuticals conference.
Click here for more.
November 02, 2006
Viral Genetics to Present at Rodman & Renshaw Healthcare Conference and The PIPEs Conference.
Click here for more.
October 30, 2006
Viral Genetics' AIDS Study Results to Be Presented at Institute of Human Virology's 2006InternationalMeeting.
Click here for more.
October 10, 2006
Dutton Associates Announces Investment Opinion.
Click here for more.
October 03, 2006
Viral Genetics Adds Two Harvard Specialists to Scientific Advisory Board.
Click here for more.
September 26, 2006
Viral Genetics to Present at EdgeWater Investment Conference.
Click here for more.
September 26, 2006
Viral Genetics to Exhibit at ICAAC.
Click here for more.
September 25, 2006
Viral Genetics Appoints Dr. Eric S. Rosenberg Chairman of Scientific Advisory Board.
Click here for more.
September 8, 2006
Viral Genetics Expands Communications to Mark US Development Program .
Click here for more.
August 11, 2006
Viral Genetics' AIDS Study Results at XVI International AIDS Conference.
Click here for more.
July 24, 2006
Viral Genetics' AIDS Study Yields Encouraging Results.
Click here for more.
June 19, 2006
Viral Genetics Announces Results of South African Study of VGV-1.
Click here for more.
April 21, 2006
Viral Genetics Updates on Release of Results of Phase III Study and Market Activity.
Click here for more.
March 31, 2006
Viral Genetics Updates on Release of Results of Phase III Study of VGV-1 for the Treatment of HIV Infection.
Click here for more.
March 29, 2006
Viral Genetics, Inc. Completes Convertible Debt Financing.
Click here for more.
February 22, 2006
Viral Genetics, Inc. Names Elizabeth Hoffman, PhD. to Board of Directors.
Click here for more.
January 11, 2006
Dr. Robert Siegel Named to Viral Genetics, Inc. Scientific and Medical Advisory Board.
Click here for more.
December 14, 2005
Viral Genetics Updates on South African Clinical Development Initiatives.
Click here for more.
June 1, 2005
Dr. Louis W. Sullivan, M.D., Joins Scientific and Medical Advisory Board of Viral Genetics, Inc.
Click here for more.
